Silexion Therapeutics - Warrants(14/08/2029) Net Tangible Assets

The latest net tangible assets for SLXNW is $44K as of June 2026. That compares with $120K in the prior-year period — down 63.3% year over year. Investors often review this figure alongside Silexion Therapeutics - Warrants(14/08/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SLXNW's net tangible assets moved from $120K to $44K — a 63.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Silexion Therapeutics - Warrants(14/08/2029)'s operating scale or balance-sheet position.

A net tangible assets figure of $44K for SLXNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLXNW's net tangible assets ($44K), review year-over-year change from $120K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.